Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-029909

Chief Executive Officer acquired 120,298 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MCCOURT Thomas A Chief Executive Officer 2024-03-08 Option exercise +120,298 1,217,948 D
Derivatives
MCCOURT Thomas A Chief Executive Officer 2024-03-08 Option exercise · Performance-based Restricted Stock Unit −120,298 0 D
Loading xslF345X05/ownership.xml…